Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
ALBIREO
🇫🇷
France
Country
🇫🇷
France
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation
Phase 2
Completed
Conditions
Chronic Constipation
Constipation
Interventions
Drug: A3309
Subscribe
First Posted Date
2009-11-03
Last Posted Date
2017-03-22
Lead Sponsor
Albireo
Target Recruit Count
190
Registration Number
NCT01007123
Locations
🇺🇸
Albireo Investigative Site, La Crosse, Wisconsin, United States
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy